Historical Earnings Track Record and Post-Report Price Behavior
CI has delivered earnings beats in 7 of its last 8 reported quarters, a beat rate of 88%, with an average earnings surprise of 0.7%. That consistency means headline EPS has beaten the consensus estimate in the vast majority of recent reports, but the average surprise is modest relative to the one-day and five-day share-price reactions investors have experienced.
The average 5-day price move in the five trading days after earnings across those eight quarters is 0.86%, classified as an "up" drift. The most recent report on 2026-07-30 showed actual EPS of $7.78 against an estimate of $7.60, a 2.4% beat, yet the stock fell 2.99% the next day and produced a 0% five-day move. The three prior reports also beat: 2026-04-30 with $7.79 versus $7.60 (2.5% surprise) led to a -2.64% next-day move and -2.25% over five days; 2026-02-05 with $8.08 versus $7.88 (2.5% surprise) led to a 2.64% next-day gain and 1.08% over five days; and 2025-10-30 with $7.83 versus $7.64 (2.5% surprise) saw a -1.09% next-day drop but a 3.76% gain over the following five days. Only one of these four one-day reactions was positive, even though every quarter was a beat.
Options-Flow Dynamics Around the October 29 Earnings Date
CI's next scheduled earnings release is 2026-10-29 before the market open, with a consensus EPS estimate of $7.50. In the run-up to that report, options flow tends to reflect both the high historical beat rate and the realization that beats have not reliably translated into immediate upward price moves. Traders following the options market typically watch for implied volatility expansion into the event, and whether the straddle market is pricing a larger one-day move than the average historical earnings reaction would justify.
With the current price at $282.54 sitting below the 50-day EMA of $286.79, the options market may also reflect a neutral-to-slightly-cautious technical setup rather than directional euphoria. The Healthcare/Medical - Healthcare Plans sector backdrop, plus the 0.86% average five-day post-earnings drift, gives participants a framework for evaluating whether premium sellers or buyers are controlling the tape heading into October 29.
What a Disciplined Trader Watches
Given CI's pattern of beating estimates while producing mixed immediate price reactions, a disciplined trader separates the EPS outcome from the market's interpretation. The 88% beat rate and 0.7% average surprise suggest the consensus has been achievable, but the four most recent beats produced next-day moves of -2.99%, -2.64%, 2.64%, and -1.09%. That dispersion is the central risk: an earnings beat does not guarantee a rally.
Technically, price at $282.54 and RSI at 45.0 leave the stock near neutral momentum and slightly under the 50-day EMA at $286.79. A trader might watch whether price reclaims or rejects the EMA heading into the October 29 report, and compare that level to the market's real expectation for the move. Post-announcement, the focus shifts to how the stock handles prior support and resistance rather than whether EPS exceeded the $7.50 estimate alone.
Frequently Asked Questions
How often has CI beaten earnings estimates?
Over the last eight reported quarters, CI has beaten the consensus EPS estimate seven times, a beat rate of 88%, with an average earnings surprise of 0.7%.
What happened after CI's most recent earnings beat on July 30, 2026?
On July 30, 2026, CI reported actual EPS of $7.78 versus an estimate of $7.60, a 2.4% beat, but the stock fell 2.99% the next day and produced a 0% move over the following five trading days.
When is CI's next earnings report and what is the current consensus?
CI's next scheduled earnings release is October 29, 2026 before the market open, with a consensus EPS estimate of $7.50.
For a deeper dive into how institutional models, quantitative signals, and options positioning are sizing up CI ahead of the October 29 report, review the full institutional verdict on the platform.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-30 | $7.78 | $7.6 | +2.4% | -2.99% | null% |
| 2026-04-30 | $7.79 | $7.6 | +2.5% | -2.64% | -2.25% |
| 2026-02-05 | $8.08 | $7.88 | +2.5% | +2.64% | +1.08% |
| 2025-10-30 | $7.83 | $7.64 | +2.5% | -1.09% | +3.76% |
| 2025-07-31 | $7.2 | $7.16 | +0.6% | - | - |
| 2025-05-02 | $6.74 | $6.35 | +6.1% | - | - |
Previous CI editions
Get the institutional verdict on CI
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CI verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.